Sign up to save your podcasts
Or
Share Cardiology Update from the 2008 ACC Annual Meeting
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Cardiology Update from the 2008 ACC Annual Meeting
Host: Paul Raeburn
Guest: Steven Nissen, MD
Host Paul Raeburn interviews Dr. Steven Nissen, chair of cardiovascular medicine at the Cleveland Clinic, at the American College of Cardiology 2008 Conference in Chicago. Dr. Nissen shares his thoughts on results from the PERISCOPE study, which measured the comparative potential for cardiovascular benefits of an insulin secretion promoter, glimepiride, and insulin sensitizer, pioglitazone. The central question: Does it matter how you lower blood sugar?
View all episodes
By ReachMDHost: Paul Raeburn
Guest: Steven Nissen, MD
Host Paul Raeburn interviews Dr. Steven Nissen, chair of cardiovascular medicine at the Cleveland Clinic, at the American College of Cardiology 2008 Conference in Chicago. Dr. Nissen shares his thoughts on results from the PERISCOPE study, which measured the comparative potential for cardiovascular benefits of an insulin secretion promoter, glimepiride, and insulin sensitizer, pioglitazone. The central question: Does it matter how you lower blood sugar?